^
Association details:
| Biomarker: | MCL1 underexpression |
|---|---|
| Cancer: | Small Cell Lung Cancer |
| Drug: | cisplatin (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Myeloid cell leukemia-1 is an important predictor of survival and progression of small cell lung cancer
Excerpt:
In term of treatment, all the patients received platinum-based chemotherapy as the first-line treatment, most of them (n=63, 90%) received cisplatin….In the univariate analysis, OS was significantly more closely associated with the patients in low Mcl-1 group than with those in high Mcl-1 group (P=0.003...).
DOI:
10.21037/atm-20-2305
